Article
Statins are potential anticancerous agents (Review)
20 Jan 2015
Abstract excerpt
Statins are inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR), which is a rate-limiting enzyme in the mevalonate pathway. The pleiotropic effects of statins may be mediated by the inhibition of downstream products such as small GTP-binding proteins, Rho, Ras and Rac whose localization and function are dependent on isoprenylation. Preclinical studies of statins in different cancer cell lines...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
